StairMed
Stub active Updated Apr 3, 2026This profile is AI-generated. If you spot an error, please help us fix it by sharing a URL to the correct information.
Founders
About
StairMed is a Shanghai-based company founded in 2021 that develops minimally invasive implantable brain-machine interface (BMI) technologies, including electrodes, systems, algorithms, and surgical robotics 1. The company focuses on enabling brain-machine integration for medical applications such as treating Parkinson’s disease and epilepsy 1. StairMed has completed clinical implants and is advancing toward large-scale multicenter registration clinical trials planned for mid-2026, aiming to enroll approximately 40 patients 2.
Funding History
| Date | Round | Amount | Lead | Co-investors |
|---|---|---|---|---|
| 2026-04-02 | Growth | ~$69M (RMB 500M) | Alibaba | Tencent, Fountainbridge Capital, OrbiMed, Oriza Seed, Qiming Venture Partners, Lilly Asia Ventures, Source Code Capital, SDIC Unity Capital 12 |
This round brings StairMed’s total funding raised in the past year to over RMB 1.1 billion 2.
What Investors Say
No verified investor quotes available at this time.
What Founders Say
No verified founder quotes available at this time.
Sources
-
Pulse2, “StairMed: RMB 500 Million (About $69 Million) Raised For Brain Machine Interface Development,” April 2026. https://pulse2.com/stairmed-rmb-500-million-about-69-million-raised-for-brain-machine-interface-development/↩↩↩
-
Medical Device Network, “StairMed raises $73m to advance BMI and DBS system development,” April 2, 2026. https://www.medicaldevice-network.com/news/stairmed-raises-73m-to-advance-bmi-and-dbs-system-development/↩↩↩